MerryMart announced its purchase of a controlling interest in a drugstore chain, Carlos Drugs-Lucena Inc. The exact terms of the transaction have not been revealed, with the only information provided being that the drugstore chain has generated positive EBITDA and net income in each of its 27 locations. This is expected to provide the business with consistent cash flow as it strives to expand its market share substantially over the next several years. MM likewise extends its portfolio (and establishes a new sub-segment along Merchandise with the pharmaceutical sectors of AC and RRHI), something they have been doing on a consistent basis with the purchase of new subsidiaries and subsidiaries acquired via acquisitions. The deal, on the other hand, does not support the high values at which the business is now trading, and the company’s rise may come to a stop sooner rather than later.

LEAVE A REPLY

Please enter your comment!
Please enter your name here